Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle A Vallerand

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|June 28, 2017
Burnout Among MD/PhD Trainees: The Forgotten SubgroupIsabelle A Vallerand
SAGE Open Medical Case Reports|May 14, 2019
Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case reportIsabelle A Vallerand, Jori Hardin
Journal of Cutaneous Medicine and Surgery|May 5, 2020
The Need for a National Strategy on Artificial Intelligence in Canadian DermatologyRyan T Lewinson, Isabelle A Vallerand
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent|May 14, 2013
Child and Adolescent Mental Health Service Management Strategies that may Influence Wait TimesIsabelle A Vallerand, John D McLennan
Current Opinion in Rheumatology|February 22, 2019
Depression and the risk of rheumatoid arthritisIsabelle A Vallerand, Scott B Patten, Cheryl Barnabe
Child and Adolescent Mental Health|September 4, 2020
Behavioural treatment recommendations in clinical practice guidelines for attention-deficit/hyperactivity disorder: a scoping reviewIsabelle A Vallerand, Anna L Kalenchuk, John D McLennan
Journal of Child and Adolescent Psychopharmacology|October 21, 2014
Treatment receipt and outcomes from a clinic employing the attention-deficit/hyperactivity disorder treatment guideline of the children's medication algorithm projectDaniel J Wagner, Isabelle A Vallerand, John D McLennan
Gut|March 22, 2019
Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation? Reply from authorsAlexandra D Frolkis, Isabelle A Vallerand, Scott B Patten, et al.
Journal of Cutaneous Medicine and Surgery|December 2, 2020
Risk of Depression in Patients With Psoriatic Disease: A Systematic Review and Meta-AnalysisAysha Lukmanji, Robert B Basmadjian, Isabelle A Vallerand, et al.
JAAD Case Reports|July 15, 2025
Concurrent superficial epidermolytic ichthyosis and generalized pustular psoriasis - Report of a case, review of the literature, and a proposed pathophysiologic linkJing Yi Han, Isabelle A Vallerand, Ahmed Shah, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Academic Medicine : Journal of the Association of American Medical Colleges|June 28, 2017
Burnout Among MD/PhD Trainees: The Forgotten SubgroupIsabelle A Vallerand
SAGE Open Medical Case Reports|May 14, 2019
Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case reportIsabelle A Vallerand, Jori Hardin
Journal of Cutaneous Medicine and Surgery|May 5, 2020
The Need for a National Strategy on Artificial Intelligence in Canadian DermatologyRyan T Lewinson, Isabelle A Vallerand
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent|May 14, 2013
Child and Adolescent Mental Health Service Management Strategies that may Influence Wait TimesIsabelle A Vallerand, John D McLennan
Current Opinion in Rheumatology|February 22, 2019
Depression and the risk of rheumatoid arthritisIsabelle A Vallerand, Scott B Patten, Cheryl Barnabe
Child and Adolescent Mental Health|September 4, 2020
Behavioural treatment recommendations in clinical practice guidelines for attention-deficit/hyperactivity disorder: a scoping reviewIsabelle A Vallerand, Anna L Kalenchuk, John D McLennan
Journal of Child and Adolescent Psychopharmacology|October 21, 2014
Treatment receipt and outcomes from a clinic employing the attention-deficit/hyperactivity disorder treatment guideline of the children's medication algorithm projectDaniel J Wagner, Isabelle A Vallerand, John D McLennan
Gut|March 22, 2019
Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation? Reply from authorsAlexandra D Frolkis, Isabelle A Vallerand, Scott B Patten, et al.
Journal of Cutaneous Medicine and Surgery|December 2, 2020
Risk of Depression in Patients With Psoriatic Disease: A Systematic Review and Meta-AnalysisAysha Lukmanji, Robert B Basmadjian, Isabelle A Vallerand, et al.
JAAD Case Reports|July 15, 2025
Concurrent superficial epidermolytic ichthyosis and generalized pustular psoriasis - Report of a case, review of the literature, and a proposed pathophysiologic linkJing Yi Han, Isabelle A Vallerand, Ahmed Shah, et al.
Pageof 3